Track the 중앙백신 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 중앙백신 has recorded 19 reports. Market capitalisation: €85.3bn. The latest transaction was filed on 29 April 2026 (Purchase). Among the most active insiders: 중앙백신. The full history is openly available.
19
Insider Decl.
n/a
Thresholds
€250,922
6 ops.
Buy Volume
n/a
5 ops.
Sell Volume
32Σ signal
Buys €250,922n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 5,632 of 29,063 companies
67.2
score / 100
Value
69
Quality
65
FCF yld2.2%
Earn yld7.2%
EV/EBITDA7.1x
ROE3.8%
Gross mgn49%
Net mgn13%
Debt/EBITDA0.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Central Vaccine es una empresa que opera en el sector de la salud y farmacéutico, cotizando en la bolsa XKRX. Se enfoca en el desarrollo y distribución de vacunas.